Concepedia

Author

Priyanka Kulkarni

Amgen (United States)ORCID

Also Known As

Kulkarni, Praveen Anil, P. Kulkarni, Prasann D. Kulkarni, Preethi Kulkarni, Priyanka Kulkarni, Priyanka R. Kulkarni

28

Publications

585

Citations

10

H-Index

11

Concepts

All Affiliations

Amgen (United States)Takeda (United States)Vertex Pharmaceuticals (United States)Roche (Switzerland)AstraZeneca (United Kingdom)
PK

About

Priyanka Kulkarni is an author at Amgen (United States) specializing in food safety, food choice, and nutrition assessment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

12

2

Public Health

1

1

12

3

Behavioral Sciences

1

1

12

4

Biomedical Engineering

1

1

15

5

Nutrition

1

1

12

Priyanka Kulkarni

×

8

Publications

190

Citations

8

H-Index

YearCitations

Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective

Arian Emami Riedmaier, Kevin DeMent, James E. Huckle,

The AAPS Journal

2020

93

Robust Invisible Digital Image Watermarking using Discrete Wavelet Transform

Priyanka Kulkarni, Altaaf Mulani

2015

18

Prediction of drug-induced kidney injury in drug discovery

Priyanka Kulkarni

Drug Metabolism Reviews

2021

16

Microneedles: promising technique for transdermal drug delivery.

Jaydeep Yadav, Vaidyakumar Ambadas, Priyanka Kulkarni,

International Journal of Pharma and Bio Sciences

2011

15

Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport

Priyanka Kulkarni, Ken Korzekwa, Swati Nagar

Journal of Pharmacology and Experimental Therapeutics

2016

14

P-glycoprotein Substrate Assessment in Drug Discovery: Application of Modeling to Bridge Differential Protein Expression Across In Vitro Tools

Na Li, Priyanka Kulkarni, Akshay Badrinarayanan,

Journal of Pharmaceutical Sciences

2020

12

Streamlining Food Effect Assessment — Are Repeated Food Effect Studies Needed? An IQ Analysis

Filippos Kesisoglou, Sumit Basu, Tejashree Belubbi,

The AAPS Journal

2023

12

Evaluation of drug‐drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically‐based pharmacokinetic model

Ashit Trivedi, Winnie Sohn, Priyanka Kulkarni,

Clinical and Translational Science

2021

10

Page 1